In the present study, we further considered the activation state of patient-derived ADSCs stimulated by resistin, an adipocytokine associated with adverse breast cancer progression12–15, and their impact on breast cancer cell malignancy in the tumor microenvironment. This evidence concerns the gene RETN and breast carcinoma.